<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02474472</url>
  </required_header>
  <id_info>
    <org_study_id>UT-PAIN-001</org_study_id>
    <nct_id>NCT02474472</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesia Investigation</brief_title>
  <acronym>PAIN</acronym>
  <official_title>A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to compare the efficacy of standard local anesthetic
      bupivicaine and liposomal bupivicaine in postoperative pain control both in magnitude and
      duration in patients undergoing sternotomy, thoracotomy, thoracoabdominal, and laparotomy
      incisions.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve (AUC) of Numeric Pain Scale</measure>
    <time_frame>First 72 hours after procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Brief Pain Inventory Questionnaire</measure>
    <time_frame>up to 30 postoperative days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>5-point satisfaction scale</measure>
    <time_frame>up to 30 postoperative days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A will receive the drug bupivacaine liposomal on an injectable suspension.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B will receive bupivacaine hydrochloride (HCl) on an injectable solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine hydrochloride</intervention_name>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine liposomal injectable suspension</intervention_name>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years-old or older, and

          -  Sternotomy, thoracotomy, laparotomy or thoracoabdominal incision is planned

          -  There is reasonable expectation that the patient will be extubated within 24 hours
             after surgery

        Exclusion Criteria:

          -  The patient has a known allergy to morphine or any opioid

          -  The patient has a known chronic pain disorder or takes daily opioid medication &gt; 1
             month prior to surgery

          -  The surgeon/anesthesiologist concludes that the period for intubation will be likely
             be for more than 24 hours after surgery

          -  There is anticipated difficulty communicating pain status due to language or other
             barriers at the investigator discretion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristofer M Charlton-Ouw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hosptial; Heart and Vascular Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2015</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Kristofer Charlton-Ouw</investigator_full_name>
    <investigator_title>â—¦Assistant Professor, Non-Tenure Clinical</investigator_title>
  </responsible_party>
  <keyword>Midline Laparotomy</keyword>
  <keyword>Sternotomy</keyword>
  <keyword>Thoracotomy</keyword>
  <keyword>Thoracoabdominal Incision</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>University data-sharing agreement required.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

